Found: 23
Select item for more details and to access through your institution.
Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Adenocarcinoma.
- Published in:
- World Journal of Surgery, 2016, v. 40, n. 6, p. 1477, doi. 10.1007/s00268-016-3412-6
- By:
- Publication type:
- Article
Uridine triacetate for severe 5-fluorouracil toxicity in a patient with thymidylate synthase gene variation: Potential pharmacogenomic implications.
- Published in:
- SAGE Open Medical Case Reports, 2018, v. 6, p. 1, doi. 10.1177/2050313X18786405
- By:
- Publication type:
- Article
ERBB2 (HER2) amplifications and co-occurring KRAS alterations in the circulating cell-free DNA of pancreatic ductal adenocarcinoma patients and response to HER2 inhibition.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1339302
- By:
- Publication type:
- Article
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 134, doi. 10.1007/s10637-021-01170-x
- By:
- Publication type:
- Article
Phase IB study of sorafenib and evofosfamide in patients with advanced hepatocellular and renal cell carcinomas (NCCTG N1135, Alliance).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1072, doi. 10.1007/s10637-021-01090-w
- By:
- Publication type:
- Article
A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 684, doi. 10.1007/s10637-018-0703-9
- By:
- Publication type:
- Article
Serial Circulating Free DNA Testing Can Detect New Genetic Alterations in Patients Undergoing Treatment for Pancreas Cancer... [including commentary by Daniel G. Haller].
- Published in:
- Oncology (08909091), 2020, v. 34, n. 11, p. 476
- By:
- Publication type:
- Article
Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.794009
- By:
- Publication type:
- Article
CD30-Positive Cutaneous T-Cell Lymphoma and Response to Brentuximab Vedotin: 2 Illustrative Cases.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 3, p. 319, doi. 10.1016/j.clml.2012.12.008
- By:
- Publication type:
- Article
Pharmacologic resistance in colorectal cancer: a review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2016, v. 8, n. 1, p. 57, doi. 10.1177/1758834015614530
- By:
- Publication type:
- Article
Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape.
- Published in:
- Current Treatment Options in Oncology, 2019, v. 20, n. 1, p. 1, doi. 10.1007/s11864-019-0601-1
- By:
- Publication type:
- Article
Molecular Profiling of Appendiceal Epithelial Tumors Using Massively Parallel Sequencing to Identify Somatic Mutations.
- Published in:
- Clinical Chemistry, 2014, v. 60, n. 7, p. 1004, doi. 10.1373/clinchem.2014.225565
- By:
- Publication type:
- Article
The Feasibility and safety of surgery in Patients receiving immune checkpoint inhibitors: a retrospective study.
- Published in:
- Frontiers in Oncology, 2017, p. 1, doi. 10.3389/fonc.2017.00121
- By:
- Publication type:
- Article
Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure–safety analyses in patients with metastatic pancreatic cancer.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 12, p. 1550, doi. 10.1002/psp4.12725
- By:
- Publication type:
- Article
A Review of Circulating Tumor DNA in Hepatobiliary Malignancies.
- Published in:
- Frontiers in Oncology, 2018, p. 1, doi. 10.3389/fonc.2018.00212
- By:
- Publication type:
- Article
Profound autoimmune hemolysis and Evans syndrome in two asplenic patients with babesiosis.
- Published in:
- Transfusion, 2015, v. 55, n. 3, p. 661, doi. 10.1111/trf.12901
- By:
- Publication type:
- Article
Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreas.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. e908, doi. 10.1093/oncolo/oyac189
- By:
- Publication type:
- Article
Circulating Tumor DNA‐Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 7, p. 569, doi. 10.1002/onco.13717
- By:
- Publication type:
- Article
A Systematic Review and Network Meta‐Analysis of Regorafenib and TAS‐102 in Refractory Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1174, doi. 10.1634/theoncologist.2019-0189
- By:
- Publication type:
- Article
Prognostic Significance of Neutrophil to Lymphocyte Ratio Dynamics in Patients with Hepatocellular Carcinoma Treated with Radioembolization Using Glass Microspheres.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 8, p. 2624, doi. 10.1007/s00259-020-05186-y
- By:
- Publication type:
- Article
Complete response in gallbladder cancer to erlotinib plus gemcitabine does not require mutation of the epidermal growth factor receptor gene: a case report.
- Published in:
- BMC Cancer, 2010, v. 10, p. 570, doi. 10.1186/1471-2407-10-570
- By:
- Publication type:
- Article